-- Collaboration accelerates and expands global development of Blueprint Medicines’ next-generation EGFR inhibitors with plans to bring clinical trials of BLU-945 and BLU-701 to Greater China-- While ...
The Pacific Northwest National Laboratory has developed a new blueprint for slashing emissions and energy use without much effort or cost. The Pacific Northwest National Laboratory has developed a new ...
New scientific opportunities are creating demand for more and better laboratory space. For academic and teaching institutions, this demand often leads to renovating and expanding existing research ...
CAMBRIDGE, Mass., SHANGHAI and SAN FRANCISCO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Blueprint Medicines Corporation (NASDAQ:BPMC) today announced an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback